Search research articles
Contact Us
Filters
Showing results (81-90 of 169) with videos related to
Page
of 17
Sort By:
Trials
|
September 25, 2014
Linked publications from a single trial: a thread of evidence
Douglas G Altman, Curt D Furberg, Jeremy M Grimshaw, et al.
Trials
|
March 25, 2006
Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials
Douglas G Altman, Curt D Furberg, Jeremy M Grimshaw, et al.
Journal of Clinical Epidemiology
|
August 6, 2002
Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction
Robert C Kaplan, Susan R Heckbert, Curt D Furberg, et al.
BMJ (Clinical Research Ed.)
|
September 19, 2013
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients
Jeanne Lenzer, Jerome R Hoffman, Curt D Furberg, et al.
Mayo Clinic Proceedings
|
October 2, 2013
The necessity for clinical reasoning in the era of evidence-based medicine
Allan D Sniderman, Kevin J LaChapelle, Nikodem A Rachon, et al.
The American Journal of Geriatric Cardiology
|
May 11, 2004
Medications and cardiovascular health in older adults: room for improvement in prevention and treatment
Caroline S Rhoads, Bruce M Psaty, Jean L Olson, et al.
American Journal of Hypertension
|
April 4, 2013
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels
Jean E Sealey, Michael H Alderman, Curt D Furberg, et al.
Journal of Clinical Lipidology
|
December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease
Peter P Toth, George Thanassoulis, Ken Williams, et al.
Journal of the American Heart Association
|
October 30, 2018
Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
Allan D Sniderman, George Thanassoulis, John T Wilkins, et al.
American Heart Journal
|
August 11, 2012
Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies
David Madigan, Daniel W Sigelman, James W Mayer, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 169) with videos related to
Sort By:
Page
of 17
Trials
|
September 25, 2014
Linked publications from a single trial: a thread of evidence
Douglas G Altman, Curt D Furberg, Jeremy M Grimshaw, et al.
Trials
|
March 25, 2006
Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials
Douglas G Altman, Curt D Furberg, Jeremy M Grimshaw, et al.
Journal of Clinical Epidemiology
|
August 6, 2002
Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction
Robert C Kaplan, Susan R Heckbert, Curt D Furberg, et al.
BMJ (Clinical Research Ed.)
|
September 19, 2013
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients
Jeanne Lenzer, Jerome R Hoffman, Curt D Furberg, et al.
Mayo Clinic Proceedings
|
October 2, 2013
The necessity for clinical reasoning in the era of evidence-based medicine
Allan D Sniderman, Kevin J LaChapelle, Nikodem A Rachon, et al.
The American Journal of Geriatric Cardiology
|
May 11, 2004
Medications and cardiovascular health in older adults: room for improvement in prevention and treatment
Caroline S Rhoads, Bruce M Psaty, Jean L Olson, et al.
American Journal of Hypertension
|
April 4, 2013
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels
Jean E Sealey, Michael H Alderman, Curt D Furberg, et al.
Journal of Clinical Lipidology
|
December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease
Peter P Toth, George Thanassoulis, Ken Williams, et al.
Journal of the American Heart Association
|
October 30, 2018
Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
Allan D Sniderman, George Thanassoulis, John T Wilkins, et al.
American Heart Journal
|
August 11, 2012
Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies
David Madigan, Daniel W Sigelman, James W Mayer, et al.
Page
of 17